Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Molecular Pathology
  • View item
  • Home
  • ICR Divisions
  • Molecular Pathology
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers.

Thumbnail
View/Open
Published version (2.235Mb)
Date
2022-03-18
ICR Author
Sadanandam, Anguraj
Author
Mooz, J
Riegel, K
Ps, H
Sadanandam, A
Marini, F
Klein, M
Werner, U
Roth, W
Wilken-Schmitz, A
Tegeder, I
Rajalingam, K
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
RAF kinases are highly conserved serine/threonine kinases, and among the three RAF isoforms (ARAF, BRAF, and CRAF), the pathophysiological relevance of ARAF is not well defined. Here, we show that patients with lung cancer exhibit low expression of ARAF, which is associated with lymph node metastasis and poor patient survival. We uncover that depletion of ARAF promotes anchorage-independent growth and metastasis through activation of AKT signaling in a subset of lung cancer cells. We identified that loss of ARAF was associated with an increase in ERBB3 expression in a kinase-independent manner. ARAF suppressed the promoter activity of ERBB3, and reconstitution of ARAF in ARAF-depleted cells led to the reversal of enhanced ERBB3-AKT signaling. Furthermore, ARAF inhibited neuregulin 1 (hNRG1)-mediated AKT activation through controlling ERBB3 expression via the transcription factor KLF5. Our results disclose a critical dual role for ARAF kinase in the negative regulation of ERBB3-AKT signaling, thereby suppressing tumor metastasis.
URI
https://repository.icr.ac.uk/handle/internal/5142
DOI
https://doi.org/10.1126/sciadv.abk1538
Collections
  • Molecular Pathology
Research team
Systems and Precision Cancer Medicine
Language
eng
License start date
2022-03-18
Citation
Science advances, 2022, 8 (11), pp. eabk1538 - ?

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.